This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Cg Pharmaceuticals, INC. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Sangsook Cho: Innovator in Pancreatic Cancer Treatment
Introduction
Sangsook Cho is a notable inventor based in Moraga, California. He has made significant contributions to the field of cancer treatment, particularly focusing on pancreatic cancer therapies. His innovative work has the potential to improve patient outcomes and advance medical science.
Latest Patents
Sangsook Cho holds a patent for a combination therapy involving ivaltinostat for treating pancreatic cancer. This patent addresses the treatment of subjects with low levels of serological protein biomarkers that negatively correlate with progression-free survival (PFS). His research aims to enhance the effectiveness of cancer therapies and provide new hope for patients battling this challenging disease.
Career Highlights
Sangsook Cho is associated with Cg Pharmaceuticals, Inc., where he continues to develop and refine his innovative approaches to cancer treatment. His work is characterized by a commitment to scientific excellence and a focus on improving therapeutic options for patients.
Collaborations
Sangsook Cho collaborates with Joong Myung Cho, further enhancing the research and development efforts at Cg Pharmaceuticals, Inc. Their partnership exemplifies the importance of teamwork in advancing medical innovations.
Conclusion
Sangsook Cho's contributions to pancreatic cancer treatment through his patent on ivaltinostat combination therapy highlight his role as an important inventor in the medical field. His ongoing work at Cg Pharmaceuticals, Inc. continues to pave the way for advancements in cancer therapies.